Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study

Rheumatoid arthritis (RA) patients on JAK inhibitors (JAKi) have an increased HZ risk compared to those on biologic DMARDs (bDMARDs). Recently, the Adjuvanted Recombinant Zoster Vaccine (RZV) became available worldwide, showing good effectiveness in patients with inflammatory arthritis. Nevertheless...

Descripción completa

Detalles Bibliográficos
Autores principales: Venerito, Vincenzo, Stefanizzi, Pasquale, Cantarini, Luca, Lavista, Marlea, Galeone, Maria Grazia, Di Lorenzo, Antonio, Iannone, Florenzo, Tafuri, Silvio, Lopalco, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138868/
https://www.ncbi.nlm.nih.gov/pubmed/37108130
http://dx.doi.org/10.3390/ijms24086967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138868/
https://www.ncbi.nlm.nih.gov/pubmed/37108130
http://dx.doi.org/10.3390/ijms24086967

Ejemplares similares